Published in J Xray Sci Technol on January 01, 2013
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles. Int J Mol Sci (2015) 0.80
Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev (2003) 11.29
uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol (2002) 6.24
Going deeper than microscopy: the optical imaging frontier in biology. Nat Methods (2010) 5.65
Molecular imaging in cancer. Science (2006) 5.01
A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys (2003) 2.58
Fluorescence optical diffusion tomography. Appl Opt (2003) 2.10
Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res (2009) 1.86
Structure of human urokinase plasminogen activator in complex with its receptor. Science (2006) 1.84
Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology (2007) 1.45
FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography. Nat Methods (2012) 1.44
Free-space propagation of diffuse light: theory and experiments. Phys Rev Lett (2003) 1.28
Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor. Int J Cancer (2007) 1.24
Diffuse optical tomography guided quantitative fluorescence molecular tomography. Appl Opt (2008) 1.22
The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling. J Histochem Cytochem (2001) 1.14
Three-dimensional reconstruction in free-space whole-body fluorescence tomography of mice using optically reconstructed surface and atlas anatomy. J Biomed Opt (2010) 1.12
Diffuse optical tomography of highly heterogeneous media. IEEE Trans Med Imaging (2001) 1.09
Fluorescence lifetime tomography of turbid media based on an oxygen-sensitive dye. Opt Express (2002) 1.09
Comparative evaluation of urokinase-type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells. Int J Cancer (2003) 1.08
In-vivo imaging of murine tumors using complete-angle projection fluorescence molecular tomography. J Biomed Opt (2009) 1.05
DOT guided fluorescence molecular tomography of arbitrarily shaped objects. Med Phys (2008) 1.00
Improved bioluminescence and fluorescence reconstruction algorithms using diffuse optical tomography, normalized data, and optimized selection of the permissible source region. Biomed Opt Express (2010) 0.97
Combined fluorescence and X-Ray tomography for quantitative in vivo detection of fluorophore. Technol Cancer Res Treat (2010) 0.96
Fluorescence-enhanced optical tomography using referenced measurements of heterogeneous media. IEEE Trans Med Imaging (2003) 0.95
Fast automatic segmentation of anatomical structures in x-ray computed tomography images to improve fluorescence molecular tomography reconstruction. J Biomed Opt (2010) 0.90
Quantitative bioluminescence tomography guided by diffuse optical tomography. Opt Express (2008) 0.84
Rapid analysis of iron concentrates by x-ray fluorescence spectrometry with sol-gel sample preparation technology. J Xray Sci Technol (2011) 0.77
In vivo monitoring of stem cells in Drosophila pupae using the radiative transfer equation-based fluorescence molecular tomography. Mol Imaging Biol (2011) 0.77
A CT-analogous scheme for time-domain diffuse fluorescence tomography. J Xray Sci Technol (2012) 0.77
Computer-aided classification of optical images for diagnosis of osteoarthritis in the finger joints. J Xray Sci Technol (2011) 0.77
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol (2007) 7.33
In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol (2005) 3.92
In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat Nanotechnol (2009) 3.21
Large-scale synthesis of nearly monodisperse CdSe/CdS core/shell nanocrystals using air-stable reagents via successive ion layer adsorption and reaction. J Am Chem Soc (2003) 2.87
Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin (2008) 2.15
Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res (2003) 2.09
Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer (2006) 2.04
Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small (2009) 1.93
Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res (2009) 1.86
Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem (2006) 1.83
Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation. Cardiovasc Res (2011) 1.70
Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr Drug Discov Technol (2009) 1.60
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal (2007) 1.58
A high-throughput screen for synthetic riboswitches reveals mechanistic insights into their function. Chem Biol (2007) 1.56
Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research. Cancer Res (2005) 1.49
Three-dimensional bioluminescence tomography with model-based reconstruction. Opt Express (2004) 1.48
Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology (2009) 1.47
Synergistic antimicrotubule therapy for prostate cancer. Biochem Pharmacol (2010) 1.44
Noninvasive in vivo tomographic optical imaging of cellular morphology in the breast: possible convergence of microscopic pathology and macroscopic radiology. Med Phys (2008) 1.35
Non-invasive imaging of epileptic seizures in vivo using photoacoustic tomography. Phys Med Biol (2008) 1.34
Tomographic imaging of absolute optical absorption coefficient in turbid media using combined photoacoustic and diffusing light measurements. Opt Lett (2007) 1.34
Identification and characterization of VPO1, a new animal heme-containing peroxidase. Free Radic Biol Med (2008) 1.33
Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. Nanomedicine (Lond) (2006) 1.32
KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia. J Biol Chem (2006) 1.30
Quantification of the heterogeneity in breast cancer cell lines using whole-cell impedance spectroscopy. Clin Cancer Res (2007) 1.29
Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. ACS Nano (2013) 1.28
Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating. Biomaterials (2010) 1.25
Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles. Theranostics (2012) 1.24
Diffuse optical tomography guided quantitative fluorescence molecular tomography. Appl Opt (2008) 1.22
4-D photoacoustic tomography. Sci Rep (2013) 1.21
Superantigens and streptococcal toxic shock syndrome. Emerg Infect Dis (2003) 1.17
Multispectral breast imaging using a ten-wavelength, 64 x 64 source/detector channels silicon photodiode-based diffuse optical tomography system. Med Phys (2006) 1.16
Initial evaluation of new 99mTc(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical characterization of ReCO3 analogues. Nucl Med Biol (2007) 1.15
Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood. Biomaterials (2011) 1.14
Tomographic x-ray-guided three-dimensional diffuse optical tomography of osteoarthritis in the finger joints. J Biomed Opt (2008) 1.14
Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells. Mol Pharmacol (2006) 1.14
Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET. Clin Cancer Res (2008) 1.13
Differentiation of cysts from solid tumors in the breast with diffuse optical tomography. Acad Radiol (2004) 1.13
Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice. Eur J Immunol (2005) 1.10
Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC). Lung Cancer (2005) 1.10
Rhenium analogues of promising renal imaging agents with a [99mTc(CO)3]+ core bound to cysteine-derived dipeptides, including lanthionine. Inorg Chem (2007) 1.09
Three-dimensional finite-element-based photoacoustic tomography: reconstruction algorithm and simulations. Med Phys (2007) 1.09
99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC. J Nucl Med (2004) 1.09
Fluorescence lifetime tomography of turbid media based on an oxygen-sensitive dye. Opt Express (2002) 1.09
Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Curr Drug Deliv (2011) 1.08
Luminescent CdSe/CdS core/shell nanocrystals in dendron boxes: superior chemical, photochemical and thermal stability. J Am Chem Soc (2003) 1.08
Morphologic tomography of nonspherical particles using multispectral diffusing light measurements. J Biomed Opt (2011) 1.08
Model-based microwave image reconstruction: simulations and experiments. Med Phys (2004) 1.07
Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening. Semin Oncol (2011) 1.07
Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments. Chem Biol Drug Des (2009) 1.05
Phase-contrast diffuse optical tomography pilot results in the breast. Acad Radiol (2008) 1.04
(99m)Tc(CO)3(NTA): a (99m)Tc renal tracer with pharmacokinetic properties comparable to those of (131)I-OIH in healthy volunteers. J Nucl Med (2010) 1.03
Photoacoustic imaging based on MEMS mirror scanning. Biomed Opt Express (2010) 1.03
T₁-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles. J Magn Reson Imaging (2011) 1.03
Three-dimensional diffuse optical tomography of osteoarthritis: initial results in the finger joints. J Biomed Opt (2007) 1.03
Reconstruction of optical absorption coefficient maps of heterogeneous media by photoacoustic tomography coupled with diffusion equation based regularized Newton method. Opt Express (2007) 1.02
Ultrasensitive detection and molecular imaging with magnetic nanoparticles. Analyst (2007) 1.02
c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589. PLoS One (2010) 1.01
Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells. Endocr Relat Cancer (2011) 1.01
A higher order diffusion model for three-dimensional photon migration and image reconstruction in optical tomography. Phys Med Biol (2008) 1.00
DOT guided fluorescence molecular tomography of arbitrarily shaped objects. Med Phys (2008) 1.00
Measurement of particle size distribution in mammalian cells in vitro by use of polarized light spectroscopy. Appl Opt (2004) 0.97
Imaging of particle size and concentration in heterogeneous turbid media with multispectral diffuse optical tomography. Opt Express (2004) 0.97
Design and evaluation of a hybrid photoacoustic tomography and diffuse optical tomography system for breast cancer detection. Med Phys (2012) 0.96
Three-dimensional diffuse optical tomography of bones and joints. J Biomed Opt (2002) 0.96
Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout. Anal Chem (2009) 0.95
Evaluation of breast tumor margins in vivo with intraoperative photoacoustic imaging. Opt Express (2012) 0.95
Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells. Mol Cancer Ther (2011) 0.95
Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. Mol Pharm (2010) 0.95
Gold-Speckled Multimodal Nanoparticles for Noninvasive Bioimaging. Chem Mater (2008) 0.95
Microbicidal activity of vascular peroxidase 1 in human plasma via generation of hypochlorous acid. Infect Immun (2012) 0.95
Image reconstruction scheme that combines modified Newton method and efficient initial guess estimation for optical tomography of finger joints. Appl Opt (2007) 0.93
Image-guided optical spectroscopy in diagnosis of osteoarthritis: a clinical study. Biomed Opt Express (2010) 0.93
Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors. Small (2013) 0.93
Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy. J Control Release (2010) 0.93
Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents. J Biophotonics (2012) 0.92
Integrated diffuse optical tomography and photoacoustic tomography: phantom validations. Biomed Opt Express (2011) 0.92
Quantitative two-dimensional photoacoustic tomography of osteoarthritis in the finger joints. Opt Express (2010) 0.92
Simultaneous reconstruction of acoustic and optical properties of heterogeneous media by quantitative photoacoustic tomography. Opt Express (2006) 0.92
Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting. ACS Appl Mater Interfaces (2013) 0.91
Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer. Int J Nanomedicine (2013) 0.91
Molecular mechanism of upregulation of survivin transcription by the AT-rich DNA-binding ligand, Hoechst33342: evidence for survivin involvement in drug resistance. Nucleic Acids Res (2007) 0.90
Photoacoustic tomography and fluorescence molecular tomography: a comparative study based on indocyanine green. Med Phys (2012) 0.90
Measurement of particle-size distribution and concentration in heterogeneous turbid media with multispectral diffuse optical tomography. Appl Opt (2005) 0.90
First assessment of three-dimensional quantitative photoacoustic tomography for in vivo detection of osteoarthritis in the finger joints. Med Phys (2011) 0.90
Photoacoustic tomography system for noninvasive real-time three-dimensional imaging of epilepsy. Biomed Opt Express (2012) 0.90
Quantitative three-dimensional photoacoustic tomography of the finger joints: an in vivo study. J Biomed Opt (2010) 0.90
Photoacoustic and fluorescence image-guided surgery using a multifunctional targeted nanoprobe. Ann Surg Oncol (2014) 0.89